AI-generated research brief — verify at source
Universal School Mental Health Programmes Show No Benefit and Signal Possible Harm at Long-Term Follow-Up
In a large cluster randomised trial across 153 English secondary schools, The Guide intervention produced a small but statistically significant improvement in adolescents’ intended help-seeking (standardised mean difference 0.10, 95% CI 0.02–0.19), while YAM produced no meaningful reduction in depressive symptoms (s.m.d. = 0.02, 95% CI –0.05 to 0.10); critically, both interventions were associated with higher depressive symptom scores compared with the control group at longer-term follow-up, raising concerns about potential iatrogenic effects.
What Was Studied
The AWARE trial evaluated whether two universal, school-based mental health programmes — Youth Aware of Mental Health (YAM) and The Mental Health and High School Curriculum Guide (The Guide) — could reduce depressive symptoms or improve intended help-seeking in early adolescents. YAM was assessed against a primary outcome of depressive symptom severity, while The Guide was assessed against intended help-seeking behaviour, both measured at 3–6 months post-baseline.
How It Was Studied
AWARE was a multi-school, parallel-group, cluster randomised controlled trial conducted in English secondary schools. A total of 153 schools were allocated on a 1:1:1 basis to YAM, The Guide, or a usual practice control group, with randomisation balanced across school characteristics including existing mental health provision, location, deprivation level, and urbanicity. The total participant population comprised 12,166 pupils in Year 9 (aged 13–14 years) at baseline, distributed across the three arms (YAM: 4,028; The Guide: 3,997; control: 4,141). The statistician, quantitative data analyst, and health economist were masked to group allocation throughout the study. Outcomes were assessed both at a primary 3–6 month time point and at a longer-term follow-up.
What Was Observed
- No improvement in depressive symptoms with YAM: Compared with the control group, YAM produced a negligible and statistically non-significant difference in depressive symptom scores — the effect was essentially zero and the confidence interval included no clinically meaningful benefit (s.m.d. = 0.02, 95% CI –0.05 to 0.10).
- Small improvement in intended help-seeking with The Guide: Pupils receiving The Guide showed a statistically significant, though modest, increase in intended help-seeking compared with controls (s.m.d. = 0.10, 95% CI 0.02 to 0.19), representing the sole positive primary outcome finding across the trial.
- Increased depressive symptoms in both intervention groups at longer-term follow-up: A notable and concerning signal emerged at the extended follow-up assessment: pupils in both the YAM and The Guide conditions reported higher depressive symptom scores relative to the control group, suggesting that neither intervention was benign over time and that harm cannot be excluded.
- Implementation difficulties with YAM: A meaningful subset of schools was unable to deliver the YAM programme as intended, indicating that real-world fidelity constraints may further limit its effectiveness and generalisability in the English school system.
Why This Matters
Universal school-based mental health programmes are increasingly promoted as a scalable preventative strategy given the rising prevalence of mental health problems in adolescents. The AWARE trial demonstrates that programmes with evidence of impact in other national contexts do not automatically translate effectively to English schools, and that intended benefits at short-term follow-up may mask or coexist with longer-term risks. The authors explicitly recommend that further rollout of these programmes in England be paused pending investigation of the observed increases in depressive symptoms.
How to Read This Result
Despite a robust, large-scale trial design, the unexplained longer-term increase in depressive symptoms in both intervention arms — combined with implementation fidelity problems in YAM delivery — means these results should be interpreted cautiously and warrant dedicated follow-up investigation before informing policy decisions.
Limitations
A notable minority of schools could not deliver the YAM programme with adequate fidelity, which may have diluted or distorted any potential treatment effect. The observed increase in depressive symptoms in both intervention arms at longer-term follow-up is unexplained and has not been fully characterised in terms of magnitude, persistence, or affected subgroups. While the statistician, data analyst, and economist were masked, full blinding of all parties — including school staff and pupils — was not achievable in this type of pragmatic school-based trial, introducing the possibility of performance or response bias.